000825201 001__ 825201
000825201 005__ 20210129225236.0
000825201 0247_ $$2doi$$a10.1088/1742-6596/746/1/012069
000825201 0247_ $$2ISSN$$a1742-6588
000825201 0247_ $$2ISSN$$a1742-6596
000825201 0247_ $$2Handle$$a2128/13409
000825201 0247_ $$2WOS$$aWOS:000409470900069
000825201 037__ $$aFZJ-2016-07672
000825201 082__ $$a530
000825201 1001_ $$0P:(DE-HGF)0$$aNawroth, T.$$b0$$eCorresponding author
000825201 245__ $$aTarget Nanoparticles for Therapy - SANS and DLS of Drug Carrier Liposomes and Polymer Nanoparticles
000825201 260__ $$aBristol$$bIOP Publ.$$c2016
000825201 3367_ $$2DRIVER$$aarticle
000825201 3367_ $$2DataCite$$aOutput Types/Journal article
000825201 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1484058771_19267
000825201 3367_ $$2BibTeX$$aARTICLE
000825201 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000825201 3367_ $$00$$2EndNote$$aJournal Article
000825201 520__ $$aT arget Nano-Pharmaceutics shall improve therapy and diagnosis of severe diseases, e.g. cancer, by individual targeting of drug-loaded nano-pharmaceuticals towards cancer cells, and drug uptake receptors in other diseases. Specific ligands, proteins or cofactors, which are recognized by the diseased cells or cells of food and drug uptake, are bound to the nanoparticle surface, and thus capable of directing the drug carriers. The strategy has two branches: a) for parenteral cancer medicine a ligand set (2-5 different, surface-linked) are selected according to the biopsy analysis of the patient tissue e.g. from tumor.; b) in the oral drug delivery part the drug transport is enforced by excipients/ detergents in combination with targeting materials for cellular receptors resulting in an induced drug uptake. Both targeting nanomaterials are characterized by a combination of SANS + DLS and SAXS or ASAXS in a feedback process during development by synthesis, nanoparticle assembly and formulation.
000825201 536__ $$0G:(DE-HGF)POF3-6G15$$a6G15 - FRM II / MLZ (POF3-6G15)$$cPOF3-6G15$$fPOF III$$x0
000825201 536__ $$0G:(DE-HGF)POF3-6G4$$a6G4 - Jülich Centre for Neutron Research (JCNS) (POF3-623)$$cPOF3-623$$fPOF III$$x1
000825201 588__ $$aDataset connected to CrossRef
000825201 65027 $$0V:(DE-MLZ)SciArea-190$$2V:(DE-HGF)$$aMedicine$$x0
000825201 65017 $$0V:(DE-MLZ)GC-130-2016$$2V:(DE-HGF)$$aHealth and Life$$x0
000825201 693__ $$0EXP:(DE-MLZ)KWS2-20140101$$1EXP:(DE-MLZ)FRMII-20140101$$5EXP:(DE-MLZ)KWS2-20140101$$6EXP:(DE-MLZ)NL3ao-20140101$$aForschungs-Neutronenquelle Heinz Maier-Leibnitz $$eKWS-2: Small angle scattering diffractometer$$fNL3ao$$x0
000825201 7001_ $$0P:(DE-HGF)0$$aJohnson, R.$$b1
000825201 7001_ $$0P:(DE-HGF)0$$aKrebs, L.$$b2
000825201 7001_ $$0P:(DE-HGF)0$$aKhoshakhlagh, P.$$b3
000825201 7001_ $$0P:(DE-HGF)0$$aLangguth, P.$$b4
000825201 7001_ $$0P:(DE-HGF)0$$aHellmann, N.$$b5
000825201 7001_ $$0P:(DE-HGF)0$$aGoerigk, G.$$b6
000825201 7001_ $$0P:(DE-HGF)0$$aBoesecke, P.$$b7
000825201 7001_ $$0P:(DE-HGF)0$$aBravin, A.$$b8
000825201 7001_ $$0P:(DE-HGF)0$$aDuc, G Le$$b9
000825201 7001_ $$0P:(DE-Juel1)145431$$aSzekely, N.$$b10$$ufzj
000825201 7001_ $$0P:(DE-HGF)0$$aSchweins, R.$$b11
000825201 773__ $$0PERI:(DE-600)2166409-2$$a10.1088/1742-6596/746/1/012069$$gVol. 746, p. 012069 -$$n1$$p012069 -$$tJournal of physics / Conference Series$$v746$$x1742-6596$$y2016
000825201 8564_ $$uhttps://juser.fz-juelich.de/record/825201/files/Nawroth_2016_J._Phys.__Conf._Ser._746_012069.pdf$$yOpenAccess
000825201 8564_ $$uhttps://juser.fz-juelich.de/record/825201/files/Nawroth_2016_J._Phys.__Conf._Ser._746_012069.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000825201 909CO $$ooai:juser.fz-juelich.de:825201$$pdnbdelivery$$pVDB$$popen_access$$pdriver$$pVDB:MLZ$$popenaire
000825201 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145431$$aForschungszentrum Jülich$$b10$$kFZJ
000825201 9131_ $$0G:(DE-HGF)POF3-6G15$$1G:(DE-HGF)POF3-6G0$$2G:(DE-HGF)POF3-600$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF3-6G15$$aDE-HGF$$bForschungsbereich Materie$$lGroßgeräte: Materie$$vFRM II / MLZ$$x0
000825201 9131_ $$0G:(DE-HGF)POF3-623$$1G:(DE-HGF)POF3-620$$2G:(DE-HGF)POF3-600$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF3-6G4$$aDE-HGF$$bForschungsbereich Materie$$lVon Materie zu Materialien und Leben$$vFacility topic: Neutrons for Research on Condensed Matter$$x1
000825201 9141_ $$y2016
000825201 915__ $$0LIC:(DE-HGF)CCBY3$$2HGFVOC$$aCreative Commons Attribution CC BY 3.0
000825201 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000825201 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000825201 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000825201 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000825201 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000825201 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000825201 920__ $$lyes
000825201 9201_ $$0I:(DE-Juel1)JCNS-FRM-II-20110218$$kJCNS (München) ; Jülich Centre for Neutron Science JCNS (München) ; JCNS-FRM-II$$lJCNS-FRM-II$$x0
000825201 980__ $$ajournal
000825201 980__ $$aVDB
000825201 980__ $$aUNRESTRICTED
000825201 980__ $$aI:(DE-Juel1)JCNS-FRM-II-20110218
000825201 9801_ $$aFullTexts